We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
24 hedge funds and large institutions have $60M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
57% more capital invested
Capital invested by funds: $38.3M → $60M (+$21.7M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 25 → 24 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
71% less call options, than puts
Call options by funds: $23K | Put options by funds: $78K
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
3
Closed
5
Calls
$23K
Puts
$78K
Net Calls
-$55K
Net Calls Change
-$55K
Top Buyers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$1.14M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$326K |
| 3 |
Renaissance Technologies
New York
|
+$200K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$88.2K |
| 5 |
Morgan Stanley
New York
|
+$44.6K |
